Term ends Jun 6, 2034 · High confidence
20-year base term ends Jun 6, 2034
Held by Pierre Fabre Medicament
Filed Dec 3, 2015 as application 14/895,919 · Granted Oct 16, 2018
Base term, 20 years from filing
Today
2014
2034
Clock starts
Jun 6, 2014
Jun 6, 2014
Term ends
Jun 6, 2034
Jun 6, 2034
Granted
Oct 16, 2018
Oct 16, 2018
base term
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
24
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 6, 2014, when application PCT/US2014/041388, the earliest non-provisional in its chain, was filed (this one was filed Dec 3, 2015) | Jun 6, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 6, 2034 | High confidence |
Partial family
| Application PCT/US2013/064147 | PCT application no patent term | no patent term |
| Application PCT/US2014/041388 | PCT application no patent term | no patent term |
| Application PCT/US2014/041399 | PCT application no patent term | no patent term |
| Application PCT/US2014/041414 | PCT application no patent term | no patent term |
| Application 62/077,085 | Pending not computed | not computed |
| Application 14/434,394 | Abandoned not computed | not computed |
| Application PCT/US2015/026461 | PCT application no patent term | no patent term |
| Application 62/153,926 | Pending not computed | not computed |
8 of 24 applications in this family shown, earliest filings first. Partial: 1 of the 24 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 26, 2016 Reel 39559, frame 41 | Lippincott, John; Van Der Horst, Edward Thein Htun; Kim, Sun Young; Presta, Leonard G. | Igenica Biotherapeutics, Inc. | Assignment of Assignor's Interest |
| Jul 14, 2017 Reel 43008, frame 945 | Igenica Biotherapeutics, Inc. | Pierre Fabre Medicament | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jun 2034
Term ends Jun 6, 2034. Maintenance fees still fall due before then
Citations
24
later US patents cite this one
That is top 25% of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.